Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Rocket Lab USA Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Rocket Lab USA Inc trades at $52.91 (market cap $37.84B). The key difference: Rocket Lab USA Inc is far larger — about 9.4× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Rocket Lab USA Inc for 29 Days on average.
| EWTX | RKLB | |
|---|---|---|
Market Cap | $4.02B | $37.84B |
Volume | 1,446,128 | 24,121,394 |
Sector | Health | Industrials |
52-Week High | $48.35 | $150.23 |
52-Week Low | $14.89 | $39.48 |
Typical Hold Time | 0 Days | 29 Days |
Enterprise Value | $3.56B | $35.67B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rocket Lab (RKLB) trades at $64.22, down 2.27% amid bearish technical signals despite recent positive business developments. The company secured its largest-ever commercial Electron deal with Synspective, expanding its launch backlog to over 100 missions. Fundamentally, RKLB shows strong revenue growth but remains unprofitable with negative margins, trading at elevated valuation multiples. Analyst sentiment remains overwhelmingly bullish with a $107 consensus price target representing significant upside potential.
The investment case balances strong growth prospects against persistent profitability challenges. While the expanding launch backlog and recent contract wins support long-term growth, the company faces execution risks amid intense competition and cash burn. Technical indicators suggest near-term weakness, but analyst consensus points to substantial upside if RKLB can achieve profitability milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
